Bürkert invests in start-up Green Elephant Biotech

Working together for a sustainable future

17-Feb-2025 - Bürkert Fluid Control Systems has taken a stake in Green Elephant Biotech as a strategic investor so the two companies can work together to develop more efficient, flexible and sustainable cell cultivation processes in the pharmaceutical and biotech industries. This partnership should enable more ...

Syphilis pathogen from the petri dish

Leibniz Institute DSMZ provides bacterium from laboratory animal-free cultivation

14-Feb-2025 - The Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures has added the syphilis pathogen to its collection and makes it available to researchers around the world for scientific studies. Until now, the bacterium Treponema pallidum subsp. pallidum could only be propagated in ...

Miniature hearts for research

Replacing animal experiments: research team has succeeded in producing a haematopoietic heart organoid for the first time

12-Dec-2024 - How do human organs develop and what happens to them when they become diseased? To answer these questions, researchers are increasingly focussing on so-called organoids. These mini-organs, just a few millimetres in size, consist of groups of cells cultivated in the laboratory that can form ...

Evonik aligns two business lines with new growth strategy

Businesses outside core areas are to be sold or discontinued

16-Oct-2024 - Evonik is reorganizing two business lines to strengthen their growth prospects. Coating & Adhesive Resins and Health Care will focus on and concentrate future investments in their respective core businesses. The remaining businesses outside these cores are to be sold to new owners or incorporated ...

A cellular model system for drug development in fatty liver disease

A 3D in vitro cell culture model as a basis for the development of new treatment strategies for one of the most common diseases in industrialized nations

12-Sep-2024 - Scientists from the Medical Faculty Mannheim, Heidelberg University have developed a model system that can be used to test the efficacy of drugs for fatty liver disease. It is a three-dimensional (3D) in vitro cell culture system based on primary human liver parenchymal cells (hepatocytes). The ...

Animal-free cell therapy from Aachen secures global growth

PL BioScience closes Series A financing in the amount of 7.8 million euros

09-Aug-2024 - PL BioScience GmbH has successfully completed a Series A financing round. The growth financing round attracted significant investments from AVANT BIO (New York), LePure Biotech (Shanghai), b.value AG (Dortmund) and better ventures (Munich). The four partners contribute their experience in deep ...

Merck Invests More Than € 300 Million in New Life Science Research Center in Germany

Research center to accelerate biopharmaceutical product development

26-Apr-2024 - Merck, a leading science and technology company, is investing more than €300 million in a new research center at its global headquarters in Darmstadt, Germany. In the Advanced Research Center, the Life Science business sector will research solutions for manufacturing antibodies, mRNA ...

Capricorn Scientific and ExcellGene Form Strategic Partnership to Support Biotech Industries

This customer-oriented approach is dedicated to accelerating the biotech journey from R&D up to clinical production

29-Feb-2024 - Capricorn Scientific GmbH and ExcellGene SA have established a strategic partnership within the biotechnology sector. Applying their collective expertise and capabilities, the collaboration seeks to help customers by optimizing processes, developing products, and offering solutions in ...

Neuromuscular 2D model for drug research

21-Dec-2023 - In neuromuscular diseases, the interaction between neurons and muscle cells is disrupted. Researchers led by Mina Gouti are now able to simulate this in 2D in a culture dish. The approach is well suited for high-throughput screening in drug research, they write in Nature Communications. Around ...

Programmable DNA hydrogels for advanced cell culture and personalized medicine

21-Aug-2023 - The team of Dr. Elisha Krieg at the Leibniz Institute of Polymer Research Dresden has developed a dynamic DNA-crosslinked matrix (DyNAtrix) by combining classical synthetic polymers with programmable DNA crosslinkers. DNA’s highly specific and predictable binding gives researchers unparalleled ...